Deborah Borst, a 74-year-old resident of Michigan, never fretted over her health, enjoying a life marked by robust well-being. Her hospital visits were limited to the joyous occasions of childbirth. However, in February 2021, her health narrative took an unexpected…
Incyte has finalized its acquisition of Escient Pharmaceuticals, a company specializing in the development of small molecule therapeutics for immune and neuro-immune disorders. The acquisition enhances Incyte’s Inflammation and Autoimmunity portfolio, reinforcing its dedication to addressing the pressing needs of…
WuXi Biologics, a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has released its 2023 Environmental, Social, and Governance (ESG) Report, showcasing significant advancements in sustainable development. Aligned with its vision and mission, WuXi Biologics’ ESG strategy is deeply…
Shionogi & Co., Ltd. recently announced that its subsidiary, Qpex Biopharma, Inc., has exercised a $10 million option granted by the Biomedical Advanced Research and Development Authority (BARDA). This additional funding, part of an ongoing partnership with BARDA, aims to…
Today, Takeda announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, of recombinant ADAMTS13 (rADAMTS13) for treating ADAMTS13 deficiency in both children and adult patients suffering from…
Sanofi to Appeal Delaware Court’s Decision on Zantac Sanofi has expressed disappointment with the recent decision by the State of Delaware court and intends to appeal. The company maintains that there is no reliable scientific evidence linking Zantac to cancer,…
Imagine a contact lens that reshapes the cornea while you sleep, improving your vision. Picture wearing a contact lens equipped with technology to alleviate the strain from increased digital screen time. These innovations and more have been made possible by…
IGC Pharma Begins Patient Enrollment for Phase 2 Alzheimer’s Agitation Trial at Neurostudies IGC Pharma has commenced patient enrollment at Neurostudies, Inc. in Port Charlotte, Florida, for its Phase 2 clinical trial investigating IGC-AD1 as a potential treatment for agitation…
A Journey from Curiosity About Life on Earth to Transformative Therapies at Novartis When I was young, my fascination with science began with the natural world and animals. A BBC Nature presenter and biologist, David Attenborough, was a significant idol…
A biopharmaceutical company specializing in genetic diseases and cancers has unveiled plans to present a series of findings at the 2024 International Symposium on Amyloidosis (ISA) in Rochester, Minnesota, from May 26 to May 30, 2024. BridgeBio Pharma will showcase…
Monkeypox, a viral disease, continues its global impact. Today, the World Health Organization (WHO) unveiled a new strategic framework aimed at guiding efforts to prevent and manage monkeypox outbreaks. The framework targets the elimination of human-to-human transmission and the reduction…
In the latest release of the World Health Statistics by the World Health Organization (WHO), the impact of the COVID-19 pandemic on global life expectancy and healthy life expectancy at birth (HALE) is starkly evident. The pandemic has reversed the…